Advertisement

Rheumatology International

, Volume 39, Issue 10, pp 1703–1710 | Cite as

Performance of 2016 revised fibromyalgia diagnostic criteria in patients with rheumatoid arthritis

  • Nada Mahmoud Shresher
  • Aly Elsayed Mohamed
  • Mohsen Hassan ElshahalyEmail author
Comorbidities
  • 82 Downloads

Abstract

Fibromyalgia (FM) is a common comorbidity in rheumatoid arthritis (RA). Recently, there were several updates for the American College of Rheumatology (ACR) FM criteria. To assess the performance of the 2016 revised ACR FM criteria in patients with RA in comparison to 1990 criteria and to study the relation to composite disease measures. This study included 130 adult RA patients fulfilling the 2010 ACR/EULAR classification criteria for RA. Patients were evaluated according to 2016 and 1990 ACR criteria for FM. Kappa agreement between the two criteria was determined. Spearman’s correlation between the polysymptomatic distress scale (PSD) and selected variables including disease activity score-28 with erythrocyte sedimentation rate (DAS-28 ESR), clinical disease activity index (CDAI), patient global assessment (PGA), and visual analogue scale (VAS) for pain was evaluated. Of the 130 RA patients, 52 patients (40%) satisfied the 2016 criteria and 40 (31.5%) the 1990 criteria. The Kappa agreement between the two criteria was 0.733. RA patients with FM had higher DAS28-ESR, CDAI, PGA, and VAS compared with those without FM. A significant positive correlation was found between the polysymptomatic Distress scale (PSD) and DAS28-ESR, CDAI, and PGA (rs 0.481, 0.516, 0.511, respectively, P < 0.001). FM coexists in a substantial number of RA patients according to the 2016 revised criteria and associated with high composite disease activity measures. Therefore, assessment of FM should be considered in RA patients with persistently high disease activity.

Keywords

Fibromyalgia Rheumatoid arthritis Prevalence Polysymptomatic distress 

Notes

Author contributions

All authors are fully responsible for the integrity of all parts of the manuscript and no part of the manuscript has been copied or previously published in whole or in part elsewhere. Study conception and design: AM and ME. Subjects recruitment and data collection: NS, AM, and ME. Data analysis: AM and ME. Writing, editing, appraising, and approving the final manuscript: All authors.

Compliance with ethical standards

Conflict of interest

All authors declare they have no conflict of interest.

Ethical approval

The study protocol was approved by the Research Ethics Committee of the Faculty of Medicine, Suez Canal University (18/7/2018-3526). All patients provided written informed consent in accordance with the ethical standards of the 2013 version of the Declaration of Helsinki.

Supplementary material

296_2019_4403_MOESM1_ESM.docx (12 kb)
Supplementary material 1 (DOCX 12 kb)

References

  1. 1.
    Branco JC, Bannwarth B, Failde I et al (2010) Prevalence of fibromyalgia: a survey in five European countries. Semin Arthritis Rheum 39:448–453.  https://doi.org/10.1016/j.semarthrit.2008.12.003 CrossRefGoogle Scholar
  2. 2.
    Duffield SJ, Miller N, Zhao S, Goodson NJ (2018) Concomitant fibromyalgia complicating chronic inflammatory arthritis: a systematic review and meta-analysis. Rheumatol (Oxf) 57(8):1453–1460.  https://doi.org/10.1093/rheumatology/key112 Google Scholar
  3. 3.
    Gist AC, Guymer EK, Eades LE, Leech M, Littlejohn GO (2018) Fibromyalgia remains a significant burden in rheumatoid arthritis patients in Australia. Int J Rheum Dis 21(6):639–646.  https://doi.org/10.1111/1756-185X.13055 CrossRefGoogle Scholar
  4. 4.
    Wolfe F, Smythe HA, Yunus MB et al (1990) The American College of Rheumatology 1990 criteria for the classification of fibromyalgia. Arthritis Rheum 33(2):160–172.  https://doi.org/10.1002/art.1780330203 CrossRefGoogle Scholar
  5. 5.
    Wolfe F, Clauw DJ, Fitzcharles M-A et al (2010) The American College of rheumatology preliminary diagnostic criteria for fibromyalgia and measurement of symptom severity. Arthritis Care Res (Hoboken) 62(5):600–610.  https://doi.org/10.1002/acr.20140 CrossRefGoogle Scholar
  6. 6.
    Wolfe F, Clauw DJ, Fitzcharles MA et al (2011) Fibromyalgia criteria and severity scales for clinical and epidemiological studies: a modification of the ACR preliminary diagnostic criteria for fibromyalgia. J Rheumatol 38(6):1113–1122.  https://doi.org/10.3899/jrheum.100594 CrossRefGoogle Scholar
  7. 7.
    Wolfe F, Clauw DJ, Fitzcharles M-A et al (2016) 2016 revisions to the 2010/2011 fibromyalgia diagnostic criteria. Semin Arthritis Rheum 46(3):319–329.  https://doi.org/10.1016/j.semarthrit.2016.08.012 CrossRefGoogle Scholar
  8. 8.
    Aletaha D, Neogi T, Silman AJ et al (2010) 2010 Rheumatoid arthritis classification criteria: an American College of Rheumatology/European League Against Rheumatism collaborative initiative. Arthritis Rheum 62(9):2569–2581.  https://doi.org/10.1002/art.27584 CrossRefGoogle Scholar
  9. 9.
    Aletaha D, Nell VPK, Stamm T et al (2005) Acute phase reactants add little to composite disease activity indices for rheumatoid arthritis: validation of a clinical activity score. Arthritis Res Ther 7(4):R796.  https://doi.org/10.1186/ar1740 CrossRefGoogle Scholar
  10. 10.
    Prevoo ML, Van’T Hof M, Kuper HH, Van Leeuwen MA, Van De Putte LB, Van Riel PL (1995) Modified disease activity scores that include twenty eight joint counts development and validation in a prospective longitudinal study of patients with rheumatoid arthritis. Arthritis Rheum 38(1):44–48.  https://doi.org/10.1002/art.1780380107 CrossRefGoogle Scholar
  11. 11.
    Hawker GA, Mian S, Kendzerska T, French M (2011) Measures of adult pain: visual Analog Scale for Pain (VAS Pain), Numeric Rating Scale for Pain (NRS Pain), McGill Pain Questionnaire (MPQ), Short-Form McGill Pain Questionnaire (SF-MPQ), Chronic Pain Grade Scale (CPGS), Short Form-36 Bodily Pain Scale (SF-36 BPS), and Measure of Intermittent and Constant Osteoarthritis Pain (ICOAP). Arthritis Care Res 63(S11):S240–S252.  https://doi.org/10.1002/acr.20543 CrossRefGoogle Scholar
  12. 12.
    El Meidany YM, El Gaafary MM, Ahmed I (2003) Cross-cultural adaptation and validation of an Arabic Health Assessment questionnaire for use in rheumatoid arthritis patients. Jt Bone Spine 70(3):195–202. https://www.ncbi.nlm.nih.gov/pubmed/12814762
  13. 13.
    Bruce B, Fries JF (2003) The Stanford Health assessment questionnaire: a review of its history, issues, progress, and documentation. J Rheumatol 30(1):167–178. https://www.ncbi.nlm.nih.gov/pubmed/12508408
  14. 14.
    El-Naby MA, Hefny MA, Fahim AE, Awadalla MA (2013) Validation of an adapted Arabic version of fibromyalgia syndrome impact questionnaire. Rheumatol Int 33(10):2561–2567.  https://doi.org/10.1007/s00296-013-2779-z CrossRefGoogle Scholar
  15. 15.
    Bennett RM, Friend R, Jones KD, Ward R, Han BK, Ross RL (2009) The revised fibromyalgia impact questionnaire (FIQR): validation and psychometric properties. Arthritis Res Ther 11(4):R120.  https://doi.org/10.1186/ar2783 CrossRefGoogle Scholar
  16. 16.
    Chan YH (2003) Biostatistics 104: correlational analysis. Singap Med J 44(12):614–619Google Scholar
  17. 17.
    McHugh ML (2012) Interrater reliability: the kappa statistic. Biochem Med 22(3):276–282CrossRefGoogle Scholar
  18. 18.
    Fan A, Pereira B, Tournadre A et al (2017) Frequency of concomitant fibromyalgia in rheumatic diseases: monocentric study of 691 patients. Semin Arthritis Rheum 47:129–132.  https://doi.org/10.1016/j.semarthrit.2017.01.005 CrossRefGoogle Scholar
  19. 19.
    Gheita TA, Sayed S, Gheita HA, Kenawy SA (2016) Vitamin D status in rheumatoid arthritis patients: relation to clinical manifestations, disease activity, quality of life and fibromyalgia syndrome. Int J Rheum Dis 19(3):249–259.  https://doi.org/10.1111/1756-185x.12426 CrossRefGoogle Scholar
  20. 20.
    Heidari F, Afshari M, Moosaadeh M (2017) Prevalence of fibromyalgia in general population and patients, a systematic review and meta analysis. Rheumatol Int 37:1527–1539.  https://doi.org/10.1007/s00296-017-3725-2 CrossRefGoogle Scholar
  21. 21.
    Jones GT, Atzeni F, Beasley M, Flüß E, Sarzi Puttini P, Macfarlane GJ (2015) The prevalence of fibromyalgia in the general population: a comparison of the American College of Rheumatology 1990, 2010, and modified 2010 classification criteria. Arthritis Rheum 67(2):568–575.  https://doi.org/10.1002/art.38905 CrossRefGoogle Scholar
  22. 22.
    Walitt B, Nahin RL, Katz RS, Bergman MJ, Wolfe F (2015) The prevalence and characteristics of fibromyalgia in the 2012 National health interview survey. PloS One 10:e0138024CrossRefGoogle Scholar
  23. 23.
    Vincent A, Lahr BD, Wolfe F et al (2013) Prevalence of fibromyalgia: a population-based study in Olmsted County, Minnesota, utilizing the Rochester epidemiology project. Arthritis Care Res 62(5):786–792.  https://doi.org/10.1002/acr.21896 CrossRefGoogle Scholar
  24. 24.
    Haliloglu S, Carlioglu A, Akdeniz D, Karaaslan Y, Kosar A (2014) Fibromyalgia in patients with other rheumatic diseases: prevalence and relationship with disease activity. Rheumatol Intl 34(9):1275–1280.  https://doi.org/10.1007/s00296-014-2972-8 CrossRefGoogle Scholar
  25. 25.
    Dhir V, Lawrence A, Aggarwal A, Misra R (2009) Fibromyalgia is common and adversely affects pain and fatigue perception in North Indian patients with rheumatoid arthritis. J Rheumatol 36(11):2443–2448.  https://doi.org/10.3899/jrheum.090157 CrossRefGoogle Scholar
  26. 26.
    Joharatnam N, McWilliams DF, Wilson D, Wheeler M, Pande I, Walsh DA (2015) A cross-sectional study of pain sensitivity, disease-activity assessment, mental health, and fibromyalgia status in rheumatoid arthritis. Arthritis Res Ther 17(1):11.  https://doi.org/10.1186/s13075-015-0525-5 CrossRefGoogle Scholar
  27. 27.
    Nawito Z, Rady HM, Maged LA (2013) The impact of fibromyalgia on disease assessment in rheumatoid arthritis patients. Egypt Rheumatol 35(3):115–119.  https://doi.org/10.1016/j.ejr.2013.03.003 CrossRefGoogle Scholar
  28. 28.
    El-Rabbat MS, Mahmoud NK, Gheita TA (2018) Clinical significance of fibromyalgia syndrome in different rheumatic diseases: relation to disease activity and quality of life. Reumatol Clin 14(5):285–289.  https://doi.org/10.1016/j.reuma.2017.02.008 CrossRefGoogle Scholar
  29. 29.
    Provan SA, Austad C, Halsaa V, Hammer HB, Kvien TK, Uhlig T (2019) Fibromyalgia in patients with rheumatoid arthritis. A 10-year follow-up study, results from the Oslo Rheumatoid Arthritis Register. Clin Exp Rheumatol. 37 Suppl 116(1):58–62. http://www.ncbi.nlm.nih.gov/pubmed/30620293
  30. 30.
    Ahmed S, Aggarwal A, Lawrence A (2019) Performance of the American College of Rheumatology 2016 criteria for fibromyalgia in a referral care setting. Rheumatol Intl 39:1397–1403.  https://doi.org/10.1007/s00296-019-04323-7 CrossRefGoogle Scholar
  31. 31.
    Wolfe F, Walitt B, Perrot S, Rasker JJ, Häuser W (2018) Fibromyalgia diagnosis and biased assessment: sex, prevalence and bias. PLoS One 13(9):1–14.  https://doi.org/10.1371/journal.pone.0203755 Google Scholar
  32. 32.
    Arout CA, Sofuoglu M, Bastian LA, Rosenheck RA (2018) Gender differences in the prevalence of fibromyalgia and in concomitant medical and psychiatric disorders: a national veterans health administration study. J Women’s Heal 27(8):1035–1044.  https://doi.org/10.1089/jwh.2017.6622 CrossRefGoogle Scholar
  33. 33.
    Fillingim RB, King CD, Ribeiro-Dasilva MC, Rahim-Williams B, Riley JL (2009) Sex, gender, and pain: a review of recent clinical and experimental findings. J Pain 10(5):447–485.  https://doi.org/10.1016/j.jpain.2008.12.001 CrossRefGoogle Scholar
  34. 34.
    Pollard LC, Kingsley GH, Choy EH, Scott DL (2010) Fibromyalgic rheumatoid arthritis and disease assessment. Rheumatology 49(5):924–928.  https://doi.org/10.1093/rheumatology/kep458 CrossRefGoogle Scholar
  35. 35.
    Ranzolin A, Brenol JCT, Bredemeier M et al (2009) Association of concomitant fibromyalgia with worse disease activity score in 28 joints, health assessment questionnaire, and short form 36 scores in patients with rheumatoid arthritis. Arthritis Rheum 61(6):794–800.  https://doi.org/10.1002/art.24430 CrossRefGoogle Scholar
  36. 36.
    Coury F, Rossat A, Tebib A et al (2009) Rheumatoid arthritis and fibromyalgia: a frequent unrelated association complicating disease management. J Rheumatol 36(1):58–62.  https://doi.org/10.3899/jrheum.080366 CrossRefGoogle Scholar
  37. 37.
    Kim H, Cui J, Frits M et al (2017) Fibromyalgia and the prediction of two-year changes in functional status in rheumatoid arthritis patients. Arthritis Care Res 69(12):1871–1877.  https://doi.org/10.1002/acr.23216 CrossRefGoogle Scholar
  38. 38.
    Lage-Hansen PR, Chrysidis S, Lage-Hansen M, Hougaard A, Ejstrup L, Amris K (2016) Concomitant fibromyalgia in rheumatoid arthritis is associated with the more frequent use of biological therapy: a cross-sectional study. Scand J Rheumatol 45(1):45–48.  https://doi.org/10.3109/03009742.2015.1046484 CrossRefGoogle Scholar
  39. 39.
    da Chakr RM, Brenol SC, Ranzolin A et al (2016) Rheumatoid arthritis seems to have DMARD treatment decision influenced by fibromyalgia. Rev Bras Reumatol 57(5):403–411.  https://doi.org/10.1016/j.rbr.2016.11.004 CrossRefGoogle Scholar
  40. 40.
    Salaffi F, Gerardi MC, Atzeni F et al (2017) The influence of fibromyalgia on achieving remission in patients with long-standing rheumatoid arthritis. Rheumatol Int 37(12):2035–2042.  https://doi.org/10.1007/s00296-017-3792-4 CrossRefGoogle Scholar
  41. 41.
    Basu N, Kaplan CM, Ichesco E et al (2018) Neurobiologic features of fibromyalgia are also present among rheumatoid arthritis patients. Arthritis Rheumatol 70(7):1000–1007.  https://doi.org/10.1002/art.40451 CrossRefGoogle Scholar
  42. 42.
    Wolfe F, Michaud K, Busch RE et al (2014) Polysymptomatic distress in patients with rheumatoid arthritis: understanding disproportionate response and its spectrum. Arthritis Care Res 66(10):1465–1471.  https://doi.org/10.1002/acr.22300 CrossRefGoogle Scholar
  43. 43.
    Wolfe F, Walitt B, Rasker JJ, Hauser W (2019) Primary and secondary fibromyalgia are the same: the universality of polysymptomatic distress. J Rheumatol 46(2):204–212.  https://doi.org/10.3899/jrheum.180083 CrossRefGoogle Scholar
  44. 44.
    Segura-Jiménez V, Aparicio VA, Álvarez-Gallardo IC et al (2014) Validation of the modified 2010 American College of Rheumatology diagnostic criteria for fibromyalgia in a Spanish population. Rheumatol (UK) 53(10):1803–1811.  https://doi.org/10.1093/rheumatology/keu169 CrossRefGoogle Scholar
  45. 45.
    Mian AN, Chaabo K, Wajed J et al (2016) Rheumatoid arthritis patients with fibromyalgic clinical features have significantly less synovitis as defined by power Doppler ultrasound. BMC Musculoskelet Disord 17:404.  https://doi.org/10.1186/s12891-016-1258-6 CrossRefGoogle Scholar
  46. 46.
    Da Silva Chakr RM, Brenol JCT, Behar M et al (2015) Is ultrasound a better target than clinical disease activity scores in rheumatoid arthritis with fibromyalgia? A case-control study. PLoS One 10(3):e0118620.  https://doi.org/10.1371/journal.pone.0118620 CrossRefGoogle Scholar

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of Physical Medicine, Rheumatology and RehabilitationDamietta Specialized HospitalDamiettaEgypt
  2. 2.Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of MedicineSuez Canal UniversityIsmailiaEgypt

Personalised recommendations